Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENZALUTAMIDE for Prostatic specific antigen increased: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 199 adverse event reports in the FDA FAERS database where ENZALUTAMIDE was used for Prostatic specific antigen increased.

Most Reported Side Effects for ENZALUTAMIDE

Side Effect Reports % Deaths Hosp.
Fatigue 8,891 18.1% 594 1,115
Death 6,680 13.6% 6,677 702
Malignant neoplasm progression 4,696 9.5% 1,482 695
Prostatic specific antigen increased 3,731 7.6% 321 463
Asthenia 3,589 7.3% 386 785
Drug ineffective 3,468 7.0% 235 275
Hot flush 3,144 6.4% 119 262
Decreased appetite 3,069 6.2% 413 811
Nausea 2,898 5.9% 264 554
Dizziness 2,776 5.6% 201 503
Diarrhoea 2,470 5.0% 209 473
Underdose 2,017 4.1% 393 320
Back pain 1,997 4.1% 185 356
Arthralgia 1,821 3.7% 114 243
Constipation 1,629 3.3% 136 296

Other Indications for ENZALUTAMIDE

Prostate cancer (25,954) Product used for unknown indication (9,434) Hormone-refractory prostate cancer (8,881) Prostate cancer metastatic (3,171) Metastases to bone (439) Neoplasm prostate (401) Neoplasm malignant (297) Hormone-dependent prostate cancer (289) Bone cancer (213) Prostate cancer stage iv (208)

Other Drugs Used for Prostatic specific antigen increased

LEUPROLIDE (64) ABIRATERONE (40) BICALUTAMIDE (25) FINASTERIDE (21) RELUGOLIX (15) DENOSUMAB (14) DEGARELIX (13) TAMSULOSIN (12) APALUTAMIDE (11) CIPROFLOXACIN (11)

Related Pages

ENZALUTAMIDE Full Profile All Prostatic specific antigen increased Drugs ENZALUTAMIDE Demographics ENZALUTAMIDE Timeline